GFRAL and cancer: In addition, in patients with cancer, reduction of GDF-15 through inhibiting of its receptor GFRAL, led to a treatment for cancer cachexia decreasing several atrophy-related genes such as atrogen1, Gadd45α, and Bnip3 [41].